196 related articles for article (PubMed ID: 32244350)
1. (20S)G-Rh2 Inhibits NF-κB Regulated Epithelial-Mesenchymal Transition by Targeting Annexin A2.
Wang YS; Li H; Li Y; Zhang S; Jin YH
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32244350
[TBL] [Abstract][Full Text] [Related]
2. The identification of molecular target of (20S) ginsenoside Rh2 for its anti-cancer activity.
Wang YS; Lin Y; Li H; Li Y; Song Z; Jin YH
Sci Rep; 2017 Sep; 7(1):12408. PubMed ID: 28963461
[TBL] [Abstract][Full Text] [Related]
3. (20S) Ginsenoside Rh2 Inhibits STAT3/VEGF Signaling by Targeting Annexin A2.
Wang YS; Chen C; Zhang SY; Li Y; Jin YH
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502195
[TBL] [Abstract][Full Text] [Related]
4. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
[TBL] [Abstract][Full Text] [Related]
5. Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling.
Cheng C; Ji Z; Sheng Y; Wang J; Sun Y; Zhao H; Li X; Wang X; He Y; Yao J; Wang L; Zhang C; Guo Y; Zhang J; Gao WQ; Zhu HH
Theranostics; 2018; 8(17):4633-4648. PubMed ID: 30279728
[TBL] [Abstract][Full Text] [Related]
6. Identification of natural compounds targeting Annexin A2 with an anti-cancer effect.
Wang YS; Li H; Li Y; Zhu H; Jin YH
Protein Cell; 2018 Jun; 9(6):568-579. PubMed ID: 29508276
[TBL] [Abstract][Full Text] [Related]
7. 20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.
Yuan Y; Wang J; Xu M; Zhang Y; Wang Z; Liang L; Sun P
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141497
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rh2 induces apoptosis and inhibits epithelial-mesenchymal transition in HEC1A and Ishikawa endometrial cancer cells.
Kim JH; Kim M; Yun SM; Lee S; No JH; Suh DH; Kim K; Kim YB
Biomed Pharmacother; 2017 Dec; 96():871-876. PubMed ID: 29078265
[TBL] [Abstract][Full Text] [Related]
10. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and stemness.
Wang J; Tian L; Khan MN; Zhang L; Chen Q; Zhao Y; Yan Q; Fu L; Liu J
Cancer Lett; 2018 Feb; 415():73-85. PubMed ID: 29199005
[TBL] [Abstract][Full Text] [Related]
12. Hypaconitine inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses adhesion, migration, and invasion of lung cancer A549 cells.
Feng HT; Zhao WW; Lu JJ; Wang YT; Chen XP
Chin J Nat Med; 2017 Jun; 15(6):427-435. PubMed ID: 28629532
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.
Zheng L; Foley K; Huang L; Leubner A; Mo G; Olino K; Edil BH; Mizuma M; Sharma R; Le DT; Anders RA; Illei PB; Van Eyk JE; Maitra A; Laheru D; Jaffee EM
PLoS One; 2011 Apr; 6(4):e19390. PubMed ID: 21572519
[TBL] [Abstract][Full Text] [Related]
14. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
[TBL] [Abstract][Full Text] [Related]
15. Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer.
Jung H; Kim JS; Kim WK; Oh KJ; Kim JM; Lee HJ; Han BS; Kim DS; Seo YS; Lee SC; Park SG; Bae KH
Cell Death Dis; 2015 Jan; 6(1):e1606. PubMed ID: 25611381
[TBL] [Abstract][Full Text] [Related]
16. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
18. Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition.
Liu T; Liu P; Ding F; Yu N; Li S; Wang S; Zhang X; Sun X; Chen Y; Wang F; Zhao Y; Li B
Oncol Rep; 2015 Feb; 33(2):861-7. PubMed ID: 25502786
[TBL] [Abstract][Full Text] [Related]
19. Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-κB/slug/E-cadherin pathway.
Zhou P; Wang C; Hu Z; Chen W; Qi W; Li A
BMC Cancer; 2017 Dec; 17(1):813. PubMed ID: 29202800
[TBL] [Abstract][Full Text] [Related]
20. Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.
Chen CY; Lin YS; Chen CL; Chao PZ; Chiou JF; Kuo CC; Lee FP; Lin YF; Sung YH; Lin YT; Li CF; Chen YJ; Chen CH
Oncotarget; 2015 Sep; 6(29):26946-59. PubMed ID: 26196246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]